Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Development of Epstein-Barr Virus Vaccines

Development of Epstein-Barr Virus Vaccines

Morgan, Andrew J.

Hardcover

Series: Medical Intelligence Unit (Unnumbered)

Medical Reference

Currently unavailable to order

ISBN10: 1570591121
ISBN13: 9781570591129
Publisher: Springer Nature
Published: Jan 1 1995
Pages: 126
Language: English
This reference reviews the development of Epstein-Barr virus vaccines that may ultimately eliminate or reduce the incidence of the cancers associated with this virus in humans. These include nasopharyngeal carcinoma, endemic Burkitts lymphoma and certain lymphomas that occur with a relatively high frequency in immunosuppressed patients and AIDS sufferers. Such vaccines may also be deployed in the prevention of infectious mononucleosis, a disease that, although rarely fatal, has significant social and economic impact on the young adult population in the Western world. Human trials of the vaccines developed to date have not been carried out but are planned for the near future. Several candidate vaccines based on recombinant viral envelope glycoproteins and a range of viral vectors are evaluated in a primate animal model of lymphoma induced by the virus.

Also in

Medical Reference

View All